Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Minerva Neurosciences, Inc.
Market Cap
$160.27M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$159.22M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$156.90M
Net Profit Margin
-6.94%
TTM Avg
-8.61%
3Y Avg
-17.97%
5Y Avg
-12.59%
Market Cap
$163.00M
Net Profit Margin
-257.10%
TTM Avg
-196.56%
3Y Avg
-155.96%
5Y Avg
-114.00%
Market Cap
$163.69M
Net Profit Margin
-80.29%
TTM Avg
-52.87%
3Y Avg
-55.88%
5Y Avg
-51.71%
Market Cap
$153.91M
Net Profit Margin
-19.62%
TTM Avg
-42.25%
3Y Avg
-45.95%
5Y Avg
-49.32%
Market Cap
$165.66M
Net Profit Margin
4.66%
TTM Avg
-8.57%
3Y Avg
-15.00%
5Y Avg
-10.75%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $160.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| PepGen Inc. (PEPG)vs › | $159.73M | 0.00% | 0.00% | 0.00% | 0.00% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -10.40% | -6.28% | -16.07% | -47.85% |
| Inogen, Inc. (INGN)vs › | $156.90M | -6.94% | -8.61% | -17.97% | -12.59% |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -257.10% | -196.56% | -155.96% | -114.00% |
| Quanterix Corporation (QTRX)vs › | $163.69M | -80.29% | -52.87% | -55.88% | -51.71% |
| Neuronetics, Inc. (STIM)vs › | $153.91M | -19.62% | -42.25% | -45.95% | -49.32% |
| Nkarta, Inc. (NKTX)vs › | $168.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| OptimizeRx Corp. (OPRX)vs › | $165.66M | 4.66% | -8.57% | -15.00% | -10.75% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $152.82M | N/A | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 71.71% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
